Login

December 2011 January 2012 February 2012
Saturday, January 28, 2012
Random Picture (B_duttonii spiroketer.jpg)
Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31
Home
Welcome to the Laboratory for Molecular Infection Medicine Sweden (MIMS)
The Nordic EMBL Partnership for Molecular Medicine

macrophages_SalmonellaMIMS is the Swedish node of the Nordic EMBL Partnership for Molecular Medicine. This partnership was established in 2007 as a joint venture between the European Molecular Biology Laboratory (EMBL) and the Universities of Helsinki, Finland, Oslo, Norway and Umeå, Sweden, and involves building of national sister institutions in the three countries. The partnership between EMBL, the Institute for Molecular Medicine Finland (FIMM), the Centre for Molecular Medicine Norway (NCMM) and the Laboratory for Molecular Infection Medicine Sweden (MIMS) is dedicated to the growing field of life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments.

The aim of this new initiative is to strengthen Swedish research and enhance the dynamics in the field of molecular medicine, partly by promoting the career opportunities for young scientists.

Summaries on the research projects in Swedish language
Läs mer om MIMS gruppledarnas forskning på svenska

(www.umu.se)



Four PhD positions and one post doc fellowship available at MIMS
Research areas:
- Tick-borne encephalitis virus pathogenicity (1 PhD position in Anna Överby's lab)
- Adenovirus pathogenicity (2 PhD positions in Niklas Arnberg's lab)
- Genome stability and variation (1 Post-doc fellowship in Andrei Chabes' lab)
- Studies of type III secretion mechanisms in Yersinia and Pseudomonas  (1 PhD position in Åke Forsberg's lab)

Read the announcements